Molecular Screening Program to Select Molecular-Based Recommended Therapies for Metastatic Cancer Patients: Analysis from the ProfiLER Trial.
O. Tredan,Q. Wang,D. Pissaloux,P. Cassier,A. de la Fouchardiere,J. Fayette,F. Desseigne,I. Ray-Coquard,C. de la Fouchardiere,D. Frappaz,P. -E. Heudel,A. Bonneville-Levard,A. Flechon,M. Sarabi,P. Guibert,T. Bachelot,M. Perol,B. You,N. Bonnin,O. Collard,C. Leyronnas,V. Attignon,C. Baudet,E. Sohier, J. -P. Villemin,A. Viari,S. Boyault,S. Lantuejoul,S. Paindavoine, I. Treillleux, C. Rodriguez,V. Agrapart,V. Corset,G. Garin,S. Chabaud,D. Perol,J. -Y. Blay Annals of Oncology（2019）
关键词
advanced cancer,molecular profiling,precision medicine,molecular-targeted agents,decision-making
AI 理解论文
溯源树
样例
